Microbial cell factories

Antibacterial effects of selenium nanoparticles made with Proteus mirabilis, alone or combined with chitosan and ampicillin, against common drug-resistant bacteria

Updated

Abstract

Selenium nanoparticles combined with chitosan and ampicillin demonstrated superior antibacterial activity with values of 30 to 100 µg/ml against several bacterial strains.

  • Selenium nanoparticles (Se NPs) were synthesized using the Proteus mirabilis strain PQ350419 as a bio-nano-factory.
  • The combination of Se NPs, chitosan, and ampicillin (Se/CS/AMP) showed enhanced antibacterial effectiveness compared to Se NPs and ampicillin alone.
  • Se/CS/AMP was effective in preventing formation by up to 50% in certain bacterial strains.
  • The synthesized nanocomposite exhibited a strong negative surface charge, which may contribute to its stability.
  • tests indicated that Se NPs and the Se/CS/AMP nanocomposite had a reduced impact on Vero cells, suggesting relative safety.

Simplified

Key numbers

30 µg/ml
of Se/CS/AMP
values for Bacillus cereus and Staphylococcus aureus.
40.95 ± 2.34 µg/ml
CC of Se NPs
test results for Se NPs against Vero cells.
199.09 ± 2.61 µg/ml
CC of Se/CS/AMP
test results for Se/CS/AMP against Vero cells.

Full Text

What this is

  • This research focuses on the biosynthesis of selenium nanoparticles (Se NPs) using the bacterium Proteus mirabilis PQ350419.
  • It explores the combination of Se NPs with chitosan and ampicillin to enhance antibacterial and antibiofilm properties.
  • The study demonstrates the effectiveness of the Se/CS/AMP nanocomposite against multidrug-resistant bacteria, providing a potential alternative to traditional antibiotics.

Essence

  • Se/CS/AMP nanocomposite exhibits potent antibacterial activity against multidrug-resistant bacteria, outperforming Se NPs and ampicillin alone. The study emphasizes the safety and efficacy of this novel treatment.

Key takeaways

  • Se/CS/AMP demonstrated lower minimum inhibitory concentrations (MICs) compared to Se NPs alone, indicating enhanced antibacterial efficacy. The values for Se/CS/AMP were 30 µg/ml, 40 µg/ml, 60 µg/ml, and 100 µg/ml against various bacterial strains.
  • The nanocomposite significantly inhibited formation by up to 50% in Staphylococcus aureus, Klebsiella pneumoniae, and Proteus mirabilis. This suggests potential applications in preventing -related infections.
  • tests revealed that Se NPs had a CC of 40.95 ± 2.34 µg/ml, while Se/CS/AMP had a CC of 199.09 ± 2.61 µg/ml, indicating a safer profile for the nanocomposite.

Caveats

  • The study primarily focuses on in vitro results; further in vivo studies are needed to confirm the effectiveness and safety of Se/CS/AMP in clinical settings.
  • While the antibacterial properties are promising, the potential for bacterial resistance to Se NPs and the nanocomposite warrants ongoing investigation.

Definitions

  • Minimum Inhibitory Concentration (MIC): The lowest concentration of an antimicrobial agent that prevents visible growth of a microorganism.
  • Cytotoxicity: The quality of being toxic to cells, often assessed to evaluate the safety of substances.
  • Biofilm: A structured community of microbial cells embedded in a self-produced polymeric matrix attached to a surface.

Simplified

Funding

Competing interests

Declarations. Ethics approval and consent to participate: The study was carried out in accordance with the guidelines and regulations of the scientific research ethics committee, Faculty of Science, Damietta University, Egypt. Written informed consent for enrolment, screening, and specimen collection was obtained from each patient or their parents or guardians. The data of the specimens were not exposed. The cytotoxicity experiments were conducted in compliance with the IACUC (The Institutional Animal Care and Use Committee) statement for using animals in research and teaching by the local ethical committee of AUHA (Al-Azhar University Housing Animals). Competing interests: The authors declare no competing interests.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free